小微企业新三板融资问题探析

A Brief Analysis of the New Third Board Financing of Small and Micro Enterprises

由于企业自身缺陷、银行服务体系不完善、信用担保体系不健全、资本市场门槛高等原因,小微企业面临严峻的融资困境。而新三板为其直接融资提供了新渠道。以上海仁会生物在新三板的成长为例,对小微企业新三板融资的可行性进行分析,得出结论为:挂牌新三板解决了仁会生物的融资难问题,它让更多的有潜力、有爆发性的小微企业借势资本市场实现快速融资,并从新三板与小微企业两方面给出相关建议。

Due to company's own defects,the imperfect banking service system,the imperfect credit guarantee system,the excessive threshold of capital market,small and micro-sized enterprises are facing serious financing difficulties.The new 3rd board has provided a new channel for its direct financing.This paper takes the growth of Shanghai Benemae Pharmaceutical Corporation in the board as an example to analyze the feasibility of financing in the new 3rd board for small and micro-sized enterprises,and concludes that listing the new 3rd board has solved its financing difficulties,which makes more potential and explosive small and micro-sized enterprises achieve rapid financing with the help of capital market.Finally,it gives relevant recommendations for both the new 3rd board and small and micro-sized enterprises.